Impaired cell migration and proliferation at higher concentrations (0.1 to 1.0 mg/mL), thus the clinically applied dose in topical preparations (about 0.1% or 1 mg/g) may impair cell function
Mafenide
Sulfamylon®
Cytotoxic even at lower local concentrations, therefore not suitable as a topical agent
Polymyxin B sulfate in combination with neomycin sulfate
Neosporin®
Much more favorable safety profile, containing far less polymyxin B but exerting excellent antimicrobiotic effects, discussed as a well-suited topical antibiotic